Best Practices Guide

How Pharmaceutical Companies Can Protect Valuable IP

Intellectual property (IP) is the lifeblood of pharmaceutical companies. An analysis of the top 10 drug firms indicates that average R&D spend is over 20% of revenue and intangible assets.
How Pharmaceutical Companies Can Protect Valuable IP
How Pharmaceutical Companies Can Protect Valuable IP
Select language to download
Instant free access

Stop a hybrid attack

Take a self-guided tour to see how the Vectra AI Platform empowers you to stop hybrid attacks before any damage is done.

Take Self-Guided Tour

With Vectra AI, attackers don't stand a chance

Intellectual property. High-value data. Hybrid cloud infrastructure. It all adds up to a lot of vulnerabilities — and makes your company a prime target for nation-state cyberattacks. But with Attack Signal Intelligence from Vectra AI, your analysts easily keep data breaches at bay.

No items found.

Gain real-world insight into the anatomy of an attack.

Join our ensemble of security researchers, data scientists and analysts as we share over 11+ years of security-AI research and expertise with the global cybersecurity community. Through our webinars and hands-on labs, you’ll learn how to effectively leverage AI for threat detection and response and expose sophisticated attacks hiding in your environment.

Explore upcoming sessions

Trusted by experts and enterprises worldwide

FAQs

Challenge

Solution

Customer benefits

How other organizations are partnering with Vectra AI